InvestorsHub Logo
Followers 22
Posts 2636
Boards Moderated 0
Alias Born 03/26/2013

Re: None

Wednesday, 12/11/2019 8:52:40 PM

Wednesday, December 11, 2019 8:52:40 PM

Post# of 70355
AURORA DETAILS ON GERMANY.. During his presentation at the Las Vegas conference, Battley was asked by an audience member to elaborate on the “proprietary step.”

Battley explained that it is a process to ensure the quality of the products, specifically microbial levels.

“We realized we needed a permit,” Battley said, adding that “obviously, we’re a little red faced on that. Nobody likes an operational hiccup.”

He was referencing the special permit that’s required to distribute irradiated medical cannabis products in Germany.

Aurora’s spokesperson said products for the German market are sourced from a European Union Good Manufacturing Practice (GMP)-certified facility and “undergo a proprietary sterilization process, called e-beam, which does not affect the efficacy or quality of the product.”

The spokesperson also confirmed that all the Alberta company’s product sales have been “temporarily paused” in Germany, including extracts.

At his Investor Intelligence appearance, Battley estimated “it’s going to take about four weeks” for Aurora to get the required permit. He also expressed confidence the company will “win” the German market after resolving the permit issue.

The spokesperson said Aurora anticipates restarting sales “in the very near future. ”https://mjbizdaily.com/aurora-details-why-it-was-forced-to-temporarily-stop-medical-cannabis-sales-in-germany/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACB News